Decipher Labs Ltd
BSE:524752
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Decipher Labs Ltd
Accounts Receivables
Decipher Labs Ltd
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Decipher Labs Ltd
BSE:524752
|
Accounts Receivables
₹42.2m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Accounts Receivables
₹97.8B
|
CAGR 3-Years
8%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Accounts Receivables
₹69B
|
CAGR 3-Years
20%
|
CAGR 5-Years
13%
|
CAGR 10-Years
10%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Accounts Receivables
₹154B
|
CAGR 3-Years
8%
|
CAGR 5-Years
10%
|
CAGR 10-Years
8%
|
|
|
Lupin Ltd
NSE:LUPIN
|
Accounts Receivables
₹62.9B
|
CAGR 3-Years
13%
|
CAGR 5-Years
6%
|
CAGR 10-Years
7%
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Accounts Receivables
₹21.9B
|
CAGR 3-Years
8%
|
CAGR 5-Years
7%
|
CAGR 10-Years
2%
|
|
Decipher Labs Ltd
Glance View
Decipher Labs Ltd. engages in the business of manufacturing pharmaceutical formulations. The company is headquartered in Hyderabad, Telangana. The firm is involved in promoting and developing in the field of pharmaceuticals, combat drugs boasts of pharmaceutical and allied products which are manufactured in multiple locations. The company provides pharmaceutical formulations such as solid dosage forms, liquid dosage forms, and ointments. The Company’s wholly owned subsidiaries include RA Labs Pte Ltd, Singapore and ICP Solutions Private Limited, India.
See Also
What is Decipher Labs Ltd's Accounts Receivables?
Accounts Receivables
42.2m
INR
Based on the financial report for Mar 31, 2025, Decipher Labs Ltd's Accounts Receivables amounts to 42.2m INR.
What is Decipher Labs Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
-22%
Over the last year, the Accounts Receivables growth was -46%. The average annual Accounts Receivables growth rates for Decipher Labs Ltd have been -31% over the past three years , -22% over the past five years .
